Electrophysiological properties of the atrium after cardioversion of chronic atrial fibrillation: Relation to the plasma brain natriuretic peptide level

International Heart Journal

Volumn 48, Issue 4, 2007, Pages 485-496

  Okumura, Yasuo ^a   Watanabe, Ichiro ^a   Ashino, Sonoko ^a   Kofune, Masayoshi ^a   Takagi, Yasuhiro ^a   Kofune, Tatsuya ^a   Okubo, Kimie ^a   Hashimoto, Kenichi ^a   Shindo, Atsushi ^a   Sugimura, Hidezou ^a   Nakai, Toshiko ^a   Kasamaki, Yuji ^a   Saito, Satoshi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial fibrillation; Brain natriuretic peptide; Filtered P wave duration; Monophasic action potential

Indexed keywords

BEPRIDIL; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL;

ACTION POTENTIAL; ADULT; AGED; ARTICLE; CARDIOVERSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART ELECTROPHYSIOLOGY; HEART REPOLARIZATION; HEART VENTRICLE FAILURE; HUMAN; HYPERTENSION; MALE; P WAVE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL AVERAGED ELECTROCARDIOGRAPHY;

ACTION POTENTIALS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN;

EID: 34748874674     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.48.485     Document Type: Article

References (34)

1. Mukoyama M, Nakao Y,, Saito Y, et al. Increased human brain natriuretic peptide in congestive heart failure. N Engl J Med 1990; 323: 757-8.
2. Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation 2002; 105:2328-31.
3. McCullough PA, Nowak RM McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 2002; 106:416-22.
4. Maisel AS, Krishnaswamy P, Nowak RM, et al; Breathing Not Property Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347:161-7.
5. Okumura Y, Watanabe L Nakai T, et al. Recurrence of atrial fibrillation after internal cardioversion of persistent atrial fibrillation: prognostic importance of electrophysiologic parameters. Circ J 2005; 69: 1514-20.
6. Silvet H, Young-Xu Y, Walleigh D, Ravid S. Brain natriuretic peptide is elevated in outpatients with atrial fibrillation. Am J Cardiol 2004; 92: 1124-7.
7. Lee SH, Jung JH, Choi SK et al. Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J 2006; 70: 100-4.
8. McCullough PA, Nowak R, McCord J, et al. The independent contribution to elevations in B-type natriuretic peptide from atrial fibrillation. J Am Coll Cardiol 2002; 36 (Supple): 90A.
9. Ozdemir M, Turkoglu S, Kava MG; Cengel A. Prospective randomized trial of transthoracic versus low-energy internal cardioversion in persistent atrial fibrillation. Int Heart J 2006; 47: 753-62.
10. Wijffels MC, Kirchbof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995; 92: 1954-68.
11. Morillo CA, Klein GJ, Jones DL, Guiraudon CM. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation 1995; 91: 1588-95.
12. Wijffels MC, Kirchhof CJ, Dorland R, Power J, Allessie MA. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 1997; 96: 3710-20.
13. Gaspo R, Bosch RF, Talajic M, Nattel S. Functional mechanisms underlying tachycardia-induccd sustained atrial fibrillation in a chronic dog model. Circulation 1997; 96: 4027-35.
14. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation. Time course and mechanisms. Circulation 1996; 94: 2968-74.
15. Fareh S, Villemaire C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation 1998; 98: 2202-9.
16. Franz MR, Karasik PL, Li C, Moubarak J, Chavez M. Electrical remodeling of the human atrium: similar effects in patients with chronic atrial fibrillation and atrial flutter. J Am Coll Cardiol 1997; 30: 1785-92.
17. Osaka T, Itoh A, Kodama I. Action potential remodeling in the human right atrium with chronic lone atrial fibrillation. Pacing Clin Electrophysiol 2000; 23: 960-5.
18. Daoud EG, Bogun F, Goyal R, et al. Effect of atrial fibrillation on afrial refractoriness in humans. Circulation 1996; 94: 1600-6.
19. Watanabe I, Masaki R, Ohkubo K, et al. Rate-dependent changes in atrial action potential duration after short-duration rapid atrial pacing in humans. Circ J 2002; 66: 874-5.
20. Kumagai K, Akimitsu S, Kawahira K, et al. Electrophysiological properties in chronic lone atrial fibrillation. Circulation 1991; 84:1662-8.
21. Pandozi C, Bianconi L, Villani M, et al. Electrophysiological characteristics of the human atria after cardioversion of persistent atrial fibrillation. Circulation 1998; 98: 2860-5.
22. Murgatroyd FD, Camm AJ. Atrial arrhythmias. Lancet 1993; 341: 1317-22.
23. Franz MR, Swerdlow CD, Liem LB, Schaefer J. Cycle length dependence of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained rate acceleration and deceleration, and different steady-state frequencies. J Clin Invest 1988; 82: 972-9.
24. Mabuchi N, Tsutamoto T, Maeda K, Kinoshita M. Plasma cardiac natriuretic peptides as biochemical markers of recurrence of atrial fibrillation in patients with mild congestive heart failure. Jpn Circ J 20001 64: 765-71.
25. Beck-da-Silva L, de Bold A, Fraser M, Williams K, Haddad H. Brain natriuretic peptide predicts successful cardioversion in patients with atrial fibrillation and maintenance of sinus rhythm. Can J Cardiol 2004; 20: 1245-8.
26. Kanda A, Watanabe I, Kojima T, et al. Effects of atrioventricular intervals on right atrial monophasic action potential duration during pacing or reciprocating tachycardia. Jpn Heart J 1995; 36: 439-50.
27. Shinagawa K, Li D, Leung TK, Nattel S. Consequences of atrial tachycardia-induced remodeling depend on the preexisting atrial substrate. Circulation 2002; 105: 251-7.
28. Guo XH, Gallagher MM, Poloniecki J, Yi G, Camm AJ. prognostic significance of serial P wave signal-averaged electrocardiograms following external electrical cardioversion for persistent atrial fibrillation: a prospective study Pacing Clin Electrophysiol 2003; 26: 299-304.
29. Raitt MH, Kusumoto W, Giraud GD, McAnulty JH. Electrophysiologic predictors of the recurrence of persistent atrial fibrillation within 30 days of cardioversion. Am J Cardiol 2004; 93: 107-10.
30. Elesber AA, Rosales AG, Shen WK, et al. Noninvasive assessment of acute changes in atrial electrophysiology after cardioversion by signal-averaged P-wave electrocardiography. Pacing Clin Electrophysiol 2005; 28: 135-9.
31. Cha TJ, Ehrlich JR, Zhang L, et al. Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure. Circulation 2004; 109: 412-8.
32. Knudsen CW, Omland T, Clopton P, et al. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing-not properly multinational study. J Am Coll Cardiol 2005; 46: 838-44.
33. Cha TJ, Ehrlich JR, Zhang L, Nattel S. Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure. Circulation 2004; 110: 1520-6.
34. Li D, Benardeau A, Nattel S. Contrasting efficacy of dofetilide in differing experimental models of atrial fibrilation. Circulation 2000; 102: 104-12.